Dapsone labels and packages: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 46: | Line 46: | ||
|- | |- | ||
|} | |} | ||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
==References== | ==References== | ||
Latest revision as of 22:50, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
Principal Display Panel – 25 mg Carton Label
NDC 49938-102-30
DAPSONE
Tablets USP
25 mg
30 Tablets (2 x 15 unit of use)
Rx Only
To be sold as a single unit
| [[File:|800px|thumb]] |
Principal Display Panel – 100 mg Carton Label
NDC 49938-101-30
DAPSONE
Tablets USP
100 mg
30 Tablets (2 x 15 unit of use)
Rx Only
To be sold as a single unit[1]
| [[File:|800px|thumb]] |
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.